Product Information

METHYLPHENIDATE 5 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1309 per EA under NDC 10702010001. Its NADAC has been published 458 times since Nov 15, 2017.

FDA first approved this application on May 11, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 5 MG TABLET

Methylphenidate Hydrochloride
$0.1309per EA
DEA Schedule CII

Strength

5 mg/1

Manufacturer

KVK-Tech Inc.

NDC

10702010001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206932

FDA Approved

5/11/2017

TE Code

AB

On Market Since

5/11/2017

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 458 times since Nov 15, 2017, and over the history we have for it it has declined 66.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1309 per EA
All-time high$0.3887 (Nov 15, 2017)
All-time low$0.0841 (Jul 17, 2024)
52-week high$0.1434
52-week low$0.1309
Median price$0.1303
Average price$0.1377
Largest weekly change+55.5% (Aug 21, 2024)
Weeks tracked458
Tracking sinceNov 15, 2017

Price History

1W

-1.9%

1M

-1.9%

3M

-3.6%

6M

-7.3%

1Y

-5.4%

3Y

+23.3%

5Y

+9.4%

All

-66.3%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by KVK-Tech Inc., is $0.1309 per EA (NDC 10702010001), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has declined 66.3%. It has been tracked across 458 weekly CMS publications since Nov 15, 2017.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?

Since Nov 15, 2017, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.0841 (Jul 17, 2024) to a high of $0.3887 (Nov 15, 2017), with a median of $0.1303 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 5 MG TABLET, is $0.0858 per EA — about 34% below METHYLPHENIDATE 5 MG TABLET.

Who manufactures METHYLPHENIDATE 5 MG TABLET?

METHYLPHENIDATE 5 MG TABLET (NDC 10702010001) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.